There is, I think, something ethereal about i —the square root of minus one. I remember first hearing about it at school. It seemed an odd beast at that time—an intruder hovering on the edge of reality.

Usually familiarity dulls this sense of the bizarre, but in the case of i it was the reverse: over the years the sense of its surreal nature intensified. It seemed that it was impossible to write mathematics that described the real world in …

I and i

Multilevel inverter technology has emerged recently as a very important alternative in the area of high-power medium-voltage energy control. This paper presents the most important topologies like diode-clamped inverter (neutral-point clamped), capacitor-clamped (flying capacitor), and cascaded multicell with separate DC sources. Emerging topologies like asymmetric hybrid cells and soft-switched multilevel inverters are also discussed. This paper also presents the most relevant control and modulation methods developed for this family of converters: multilevel sinusoidal pulsewidth modulation, multilevel selective harmonic elimination, and space-vector modulation. Special attention is dedicated to the latest and more relevant applications of these converters such as laminators, conveyor belts, and unified power-flow controllers. The need of an active front end at the input side for those inverters supplying regenerative loads is also discussed, and the circuit topology options are also presented. Finally, the peripherally developing areas such as high-voltage high-power devices and optical sensors and other opportunities for future development are addressed.

Multilevel inverters: a survey of topologies, controls, and applications

Summary Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. Methods In this retrospective, multicentre cohort study, we included all adult inpatients (≥18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. Findings 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1·10, 95% CI 1·03–1·17, per year increase; p=0·0043), higher Sequential Organ Failure Assessment (SOFA) score (5·65, 2·61–12·23; p Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 μg/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Funding Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; The Beijing Science and Technology Project; and Major Projects of National Science and Technology on New Drug Creation and Development.

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

background Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure. We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure. methods Patients were randomly assigned to eplerenone (25 mg per day initially, titrated to a maximum of 50 mg per day; 3313 patients) or placebo (3319 patients) in addition to optimal medical therapy. The study continued until 1012 deaths occurred. The primary end points were death from any cause and death from cardiovascular causes or hospitalization for heart failure, acute myocardial infarction, stroke, or ventricular arrhythmia. results During a mean follow-up of 16 months, there were 478 deaths in the eplerenone group and 554 deaths in the placebo group (relative risk, 0.85; 95 percent confidence interval, 0.75 to 0.96; P=0.008). Of these deaths, 407 in the eplerenone group and 483 in the placebo group were attributed to cardiovascular causes (relative risk, 0.83; 95 percent confidence interval, 0.72 to 0.94; P = 0.005). The rate of the other primary end point, death from cardiovascular causes or hospitalization for cardiovascular events, was reduced by eplerenone (relative risk, 0.87; 95 percent confidence interval, 0.79 to 0.95; P=0.002), as was the secondary end point of death from any cause or any hospitalization (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.98; P=0.02). There was also a reduction in the rate of sudden death from cardiac causes (relative risk, 0.79; 95 percent confidence interval, 0.64 to 0.97; P=0.03). The rate of serious hyperkalemia was 5.5 percent in the eplerenone group and 3.9 percent in the placebo group (P = 0.002), whereas the rate of hypokalemia was 8.4 percent in the eplerenone group and 13.1 percent in the placebo group (P<0.001). conclusions The addition of eplerenone to optimal medical therapy reduces morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.

http://jeffascenzo.com/Database%20Files/EPHESUS.pdf

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

The use of distributed energy resources is increasingly being pursued as a supplement and an alternative to large conventional central power stations. The specification of a power-electronic interface is subject to requirements related not only to the renewable energy source itself but also to its effects on the power-system operation, especially where the intermittent energy source constitutes a significant part of the total system capacity. In this paper, new trends in power electronics for the integration of wind and photovoltaic (PV) power generators are presented. A review of the appropriate storage-system technology used for the integration of intermittent renewable energy sources is also introduced. Discussions about common and future trends in renewable energy systems based on reliability and maturity of each technology are presented

/pdf/power-electronic-systems-for-the-grid-integration-of-4s5cxjhatl.pdf

Power-Electronic Systems for the Grid Integration of Renewable Energy Sources: A Survey

A 67-year-old man with a liver transplant 1 year before developed stenosis of the biliary anastomosis that required stent placement by ERCP He was admitted for cholangitis, and the stent was removed. He was readmitted for fever without an apparent focus of infection. Abdominal CT showed a gas-containing collection in the left liver lobe.

Percutaneous Drainage of Abdominal Fluid Collections

Introduction: Combining mesenchymal stem cells (MSCs) and cardiac stem cells (CSCs) has synergistic effects in reducing scar size and improving cardiac function for the treatment of ischemic cardio...

Abstract 19681: The Combination of Allogeneic Mesenchymal Stem Cells and Cardiac Stem Cells Produce Synergistic Effects in Cardiac Regeneration

Dynamic and Steady Behavior of Harmonic Filter for Compensating Resonance in Mining Systems

https://dialnet.unirioja.es/descarga/articulo/1129423.pdf

Aproximación a la situación geoestratégica de la Europa del Este en el nuevo contexto mundial

This paper presents a single phase seven-level inverter grid connected photovoltaic (PV) system application. The proposed system consists of a PV arrays, a single phase seven-level inverter interface and single phase power grid. The control of the inverter is based on a model predictive control algorithm where the main aim is to control the injected power which is produced by the PV source, to improve the quality of the current waveform, to reduce the THD of the current and to ensure the elimination of the shift phase between the injected current and the grid voltage in order to fulfill the requirement of the smart grid network. To clarify the advantages of the application of the model predictive control to the proposed topology, simulation results using MATLAB/SIMULINK and real time simulations using dSPACE 1103 are provided in this paper.

Jose Rodriguez

Papers

Percutaneous Drainage of Abdominal Fluid Collections

Abstract 19681: The Combination of Allogeneic Mesenchymal Stem Cells and Cardiac Stem Cells Produce Synergistic Effects in Cardiac Regeneration

Dynamic and Steady Behavior of Harmonic Filter for Compensating Resonance in Mining Systems

Aproximación a la situación geoestratégica de la Europa del Este en el nuevo contexto mundial

Model predictive Control ofo Single Phase Grid Connected Multilevel Inverter